Dexamethasone

Dexamethasone is a potent synthetic corticosteroid and a member of the glucocorticoid class of drugs. It is widely used in medicine for its potent anti-inflammatory and immunosuppressant effects. The medication is a key tool in managing a diverse array of conditions, from severe allergies and asthma to certain cancers and autoimmune disorders.

Medical uses

Dexamethasone is prescribed for numerous conditions due to its powerful anti-inflammatory action. It is a cornerstone in the treatment of cerebral edema associated with brain tumors or neurosurgery. In oncology, it is frequently used to manage chemotherapy-induced nausea and vomiting, and as part of treatment regimens for lymphoma, leukemia, and multiple myeloma. For rheumatologic conditions like rheumatoid arthritis and systemic lupus erythematosus, it helps control disease flares. It is also critical in managing severe asthma exacerbations, chronic obstructive pulmonary disease (COPD) flare-ups, and acute episodes of inflammatory bowel disease such as Crohn's disease. In endocrinology, it is used in the dexamethasone suppression test to diagnose Cushing's syndrome. During the COVID-19 pandemic, the RECOVERY Trial led by the University of Oxford demonstrated its life-saving benefit for hospitalized patients requiring oxygen therapy or mechanical ventilation.

Adverse effects

Prolonged use, especially at high doses, is associated with significant adverse effects reflective of Cushing's syndrome. Common issues include hyperglycemia, which can exacerbate or precipitate diabetes mellitus, and hypertension. Musculoskeletal effects include proximal myopathy, osteoporosis, and an increased risk of avascular necrosis, particularly of the femoral head. Psychiatric disturbances such as insomnia, euphoria, and psychosis may occur. It can cause peptic ulcer disease and suppress the hypothalamic-pituitary-adrenal axis, leading to adrenal insufficiency upon withdrawal. Other risks include increased susceptibility to infections, cataract formation, glaucoma, and fluid retention leading to peripheral edema. Topical use can cause skin atrophy and telangiectasia.

Pharmacology

Dexamethasone exerts its effects by crossing the cell membrane and binding with high affinity to the glucocorticoid receptor in the cytoplasm. The receptor-ligand complex then translocates to the cell nucleus, where it modulates gene transcription. It influences the expression of numerous genes involved in inflammation and immune response, leading to the inhibition of pro-inflammatory cytokines like interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α). It also promotes the synthesis of anti-inflammatory proteins such as lipocortin-1. Its pharmacokinetics include good oral bioavailability, a plasma half-life of approximately 36 to 72 hours, and metabolism primarily in the liver via the cytochrome P450 system, particularly CYP3A4, with excretion in the urine.

History

Dexamethasone was first synthesized in 1957 by Philip S. Hench and his colleagues at the Mayo Clinic, building upon the groundbreaking corticosteroid research for which Hench, along with Edward Calvin Kendall and Tadeusz Reichstein, had received the Nobel Prize in Physiology or Medicine in 1950. It was developed by the pharmaceutical company Merck & Co. and approved for medical use in the United States in 1958. Its development was part of a post-war wave of synthetic steroid innovation aimed at creating agents with greater glucocorticoid potency and reduced mineralocorticoid activity compared to hydrocortisone. A pivotal moment in its history was its role in the 2020 RECOVERY Trial, which globally altered the standard of care for severe COVID-19.

Society and culture

Dexamethasone is on the World Health Organization's List of Essential Medicines. It is available as a generic medication and is marketed under many brand names worldwide, including Decadron and Hexadrol. Its low cost and wide availability have made it a critical drug in both high-income and low-resource settings. The drug gained unprecedented public attention during the COVID-19 pandemic following the announcement of the RECOVERY Trial results, with organizations like the World Health Organization swiftly updating treatment guidelines. It has also been used in veterinary medicine and has appeared in popular culture, notably in the film *The Martian*, where it was part of a fictional medical kit.

Category:Corticosteroids Category:Glucocorticoids Category:World Health Organization essential medicines